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PPRE-CLINICAL RESEARCH
Ultrasound-Microbubble–Mediated
Intercellular Adhesion Molecule-1 Small
Interfering Ribonucleic Acid Transfection Attenuates
Neointimal Formation After Arterial Injury in Mice
Jun-ichi Suzuki, MD, PHD,*‡ Masahito Ogawa, MS,*‡ Kiyoshi Takayama, PHD,‡
Yoshiaki Taniyama, MD, PHD,§ Ryuichi Morishita, MD, PHD,§ Yasunobu Hirata, MD, PHD,*†
Ryozo Nagai, MD, PHD,† Mitsuaki Isobe, MD, PHD†
Tokyo and Osaka, Japan
Objectives The purpose of this study was to investigate the efficiency of small interfering ribonucleic acid (siRNA) in murine
arteries. We transfected it using a nonviral ultrasound-microbubble–mediated in vivo gene delivery system.
Background siRNA is an effective methodology to suppress gene function. The siRNA can be synthesized easily; however, a
major obstacle in the use of siRNA as therapeutics is the difficulty involved in effective in vivo delivery.
Methods To investigate the efficiency of nonviral ultrasound-microbubble–mediated in vivo siRNA delivery, we used a
fluorescein-labeled siRNA, green fluorescent protein (GFP) siRNA, and intercellular adhesion molecule (ICAM)-1
siRNA in murine arteries. Murine femoral arteries were injured using flexible wires to establish arterial injury.
Results The fluorescein-labeled siRNA and GFP siRNA showed that this nonviral approach could deliver siRNA into target
arteries effectively without any tissue damage and systemic adverse effects. ICAM-1 siRNA transfection into mu-
rine injured arteries significantly suppressed the development of neointimal formation in comparison to those in
the control group. Immunohistochemistry revealed that accumulation of T cells and adhesion molecule positive
cells was observed in nontreated injured arteries, whereas siRNA suppressed accumulation.
Conclusions The nonviral ultrasound-microbubble delivery of siRNA ensures effective transfection into target arteries. ICAM-1
siRNA has the potential to suppress arterial neointimal formation. Transfection of siRNA can be beneficial for
the clinical treatment of cardiovascular and other inflammatory diseases. (J Am Coll Cardiol 2010;55:904–13)
© 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.09.054e
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the most effective strategy for evaluating gene function is
sing ribozymes and ribonucleic acid (RNA) interference
1). Small interfering ribonucleic acids (siRNA) are power-
ul tools that suppress gene expression in cells (2). However,
he therapeutic application of siRNA is dependent upon the
evelopment of delivery vehicles (3). In addition, such a
elivery vehicle should be administered efficiently, safely,
nd repeatedly. However, there are only a few reports on
rom the *Department of Advanced Clinical Science and Therapeutics, Graduate
chool of Medicine, and †Department of Cardiovascular Medicine, University of
okyo, Tokyo, Japan; ‡Department of Cardiovascular Medicine, Tokyo Medical and
ental University, Tokyo, Japan; and the §Department of Clinical Gene Therapy
cience, Osaka University, Graduate School of Medicine, Osaka, Japan. This work
as supported by grants from the Grant-in-Aid from the Japanese Ministry of
ducation, Science and Culture, and the Grant-in-Aid from the Japanese Ministry of
elfare.u
Manuscript received December 11, 2008; revised manuscript received September 3,
009, accepted September 15, 2009.ffective and safe in vivo transfection of siRNA into target
rgans. Although viral vector systems are efficient for
ransfection of genes, such as short hairpin RNAs and
olecular derivatives of siRNAs, there is concern that these
ystems may adversely affect clinical utility (4). As thera-
eutic ultrasound increases cell membrane permeabilization
5), the nonviral ultrasound method increases the transfec-
ion efficiency of decoy in vivo into arteries (6), and other
See page 914
rgans. Although there are a few papers that demonstrate
onoporation using microbubble-promoted plasmid de-
xyribonucleic acid/siRNA transduction to murine hearts
7) and to joint synovium (8), there have been few reports of
he transfection of siRNA into target arteries using
ltrasound-microbubble methods.
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March 2, 2010:904–13 ICAM-1 siRNA Attenuates Neointimal FormationRecently, we reported decoy oligonucleotide transfection
nto the arteries using this methodology (9). Thus, we have
sed the fluorescein isothiocyanate (FITC)-labeled siRNA and
murine arterial injury model to study the transfection effi-
iency of siRNA using an ultrasound microbubble method into
arget arteries. Because intercellular adhesion molecule
ICAM)-1 plays a critical role for progression of inflammation
nd arterial neointimal formation (10), we examined the effects
f ICAM-1 siRNA for prevention of neointimal formation
fter arterial injury using the ultrasound-microbubble–
ediated transfection.
This is the first paper to demonstrate that the ultrasound
icrobubble method significantly increased siRNA transfec-
ion efficiency into arteries. We revealed that ICAM-1 siRNA
ransfection using this method has potential to prevent
nflammatory-related cardiovascular diseases.
ethods
reparation of siRNA-microbubble complexes. The 1,2
ioleoyl-3-trimethylammonium-propane (DOTAP) was
urchased from Roche Diagnostics (Alameda, California).
or each artery, 20-g siRNAs in 90-l transfection buffer
as transferred into a sterile Eppendorf tube. In a separate
terile polystyrene tube, 50-g DOTAP was mixed with
0-l transfection buffer with 10-l microbubble (Optison
olution [human albumin microspheres], Mallinckrodt, Ha-
elwood, Missouri), and then the siRNA mixture was
ransferred to the polystyrene tube containing the DOTAP
nd incubated at room temperature for 30 min. The mixture
hould have turned cloudy, but no precipitates or aggrega-
ion were visible. Charge ratios of DOTAP and siRNAs
aried from 1:2 to 2:1.
rterial injury models. Male wild-type mice and trans-
enic mice constitutively overexpressing enhanced green
uorescent protein (GFP [C57BL/6, age 4 to 6 weeks,
eight 20 to 25 g] 006567, Japan Charles River Laborato-
ies, Atsugi, Kanagawa, Japan) were used in this study. We
ade an arterial injury model that was modified from the
revious reports (11). Briefly, the femoral artery was looped
nd tied off with 6-0 silk sutures for temporary vascular
ontrol during the procedure. A transverse arteriotomy was
ade, and a flexible angioplasty guidewire (a curved
50-m polished copper wire) was introduced and ad-
anced 1 cm. Endothelial denudation injury of the artery
as performed by use of wire withdrawal injury, and 3
asses were made along the artery. A sham operation (no
ire injury) was also performed. The animals were fed a
tandard diet and water and were maintained in compliance
ith animal welfare guidelines of the Institute of Experi-
ental Animals, Tokyo Medical and Dental University.
he investigation conforms to the “Guide for the Care and
se of Laboratory Animals” published by the National
nstitutes of Health (NIH Publication No. 85-23, revised
996). Gransfection of FITC-labeled
iRNA into injured arteries of
ild-type mice. To study the in
ivo transfection efficiency of
iRNA, we used the FITC-labeled
iRNA and the wild-type murine
rterial injury model. FITC-
abeled siRNA (siRNA Alexa
luor 488) was purchased from
iagen K.K. (Tokyo, Japan). Im-
ediately after injury of right fem-
ral arteries, 90 l of the FITC-
abeled siRNA (20 g) plus
icrobubble (10 l) mixture was
ncubated within the arterial lu-
en. The ultrasound transducer
as held by hand, and it was at-
ached directly to the artery. The
ltrasound was irradiated for 20 s
1 MHz, 0.5 W/cm2, duty 50%) to
he artery. The siRNA transfec-
ion was performed while the ves-
el was being ligated (n  6). For
ontrol studies of injured arteries: 1) no siRNA, microbubble
nd ultrasound (n 2); 2) non–FITC-labeled siRNA without
icrobubble and ultrasound (n 4); 3) FITC-labeled siRNA
ithout microbubble and ultrasound (n  4); and 4) FITC-
abeled siRNA with microbubble but no ultrasound irradiation
n 6) were performed. Additionally, we compared the FITC
iRNA transfection efficiency between de-endothelialized ves-
els (n 6) and non–de-endothelialized vessels (n 6) using
he same ultrasound-microbubble method. The arteries and
ther organs were harvested 8 h after transfection; the
ransfection efficiency was judged using fluorescent micros-
opy. Systemic adverse effects were defined as death or
ignificant body weight loss during the observation period.
ransfection of GFP siRNA into injured arteries of GFP
ransgenic mice. To study the chronic efficiency of siRNA,
e used the GFP siRNA (AM4626, Ambion, Foster City,
alifornia) and the GFP transgenic murine arterial injury
odel. Immediately after injury of right femoral arteries of
FP transgenic mice, 90-l of GFP siRNA (20 g) plus
icrobubble (10 l) mixture was incubated within the
rterial lumen. The siRNA was simply mixed with the
icrobubbles. The flow in the femoral artery was tempo-
arily disrupted during the ultrasound-microbubble destruc-
ion. Thus, the flow was similarly disrupted during the
ontrol experiments. The ultrasound was irradiated for 20 s
1 MHz, 0.5 W/cm2, duty 50%) to the artery (n  4). For
ontrol studies: 1) no siRNA, microbubble and ultrasound
n  2); 2) GFP siRNA without microbubble and ultra-
ound (n 4); and 3) GFP siRNA with microbubble but no
ltrasound irradiation (n  4) were performed. Addition-
lly, we compared GFP expression between GFP siRNA
ransfected vessels (n  4) and remote vessels (n  4) of
Abbreviations
and Acronyms
cDNA  complementary
deoxyribonucleic acid
DOTAP  1,2 dioleoyl-3-
trimethylammonium-propane
FITC  fluorescein
isothiocyanate
GFP  green fluorescent
protein
ICAM  intercellular
adhesion molecule
MLR  mixed lymphocyte
reaction
mRNA  messenger
ribonucleic acid
RT-PCR  real-time
polymerase chain reaction
siRNA  small interfering
ribonucleic acid
VCAM  vascular cell
adhesion moleculeFP-transgenic mice. The arteries were harvested 7 days
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ICAM-1 siRNA Attenuates Neointimal Formation March 2, 2010:904–13fter transfection; the transfection efficiency was judged
sing fluorescent microscopy.
esign of ICAM-1 siRNA. We designed 7 ICAM-1
iRNA according to the murine ICAM-1 complementary
eoxyribonucleic acid (cDNA) sequence (GeneBank
X52264.1) as follows, referring to the previous report (12):
1: 5=-AAG GGC TGG CAT TGT TCT CTA-3=; S2:
=-AAC TGT GAA GTG TGA AGC CCA-3=; S3:
=-AAG TTA CAG AAG GCT CAC GAG-3=; S4:
=-AAG GAG ATC ACA TTC ACG GTG-3=; S5:
=-AAA CAG CAG TGA CTC TGT GTC-3=; S6:
=-AAC TGG AAG CTG TTT GAG CTG-3=; and S7:
=-AAG GGA GCC AAG TAA CTG TGA-3=.
ixed lymphocyte reaction for evaluation of ICAM-1
iRNA. We examined mixed lymphocyte reaction (MLR)
o assess which ICAM-1 siRNA in selected sequences is
Figure 1 Representative Findings of Injured Femoral Arteries in
(A, B) Arteries transfected with fluorescein isothiocyanate (FITC)-labeled small inte
microscopy. (A) A very faint fluorescence is seen in the target arteries because th
administered. (B) There is a significant increase of fluorescence in the artery with
Although the fluorescence observed in (A) was mainly autofluorescence, additiona
transfected into endothelial and vascular smooth muscle cells when we used the
shown. The siRNA using the ultrasound-microbubble method significantly increased
the efficiency between de-endothelialized and non–de-endothelialized vessels. *post effective in the suppression of the immune reaction.
he MLR was performed with responder lymph node cells
rom native C57BL/6J mice, and mitomycin-C–inactivated
timulator lymph node cells from naive BALB/c mice, as
escribed previously (13,14). Each ICAM-1 siRNA was
ransfected into naive responder cells using the HVJ-
iposome method (15). A total of 1  105 responder cells
ere cultured with an equal number of mitomycin-C
reated stimulator cells in 96-well plates in C/10 media.
roliferation was assessed at 37°C under 5% CO2 on day 4.
ell proliferation was assessed with the Cell Counting Kit-8
Dojindo, Tokyo, Japan), and the proliferation was evalu-
ted using the optical density (16).
ransfection of ICAM-1, vascular cell adhesion molecule
VCAM)-1, and scrambled siRNA into injured arteries. To
onfirm the in vivo efficacy of ICAM-1 siRNA to prevent
-Type Mice
ribonucleic acid (siRNA) harvested 8 h after transfection using fluorescent
s no ultrasound irradiation when FITC-labeled siRNA without microbubble was
beled siRNA and microbubble administration and ultrasound irradiation.
scence in (B) was transfected FITC. The FITC-labeled siRNA was significantly
und and microbubble method. (C) The number of FITC-positive cells per artery is
umbers compared with the other groups. There was no statistical difference in
. Scale bars  0.5 mm.Wild
rfering
ere wa
FITC-la
l fluore
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the n
 0.05
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March 2, 2010:904–13 ICAM-1 siRNA Attenuates Neointimal Formationeointimal formation, we used the murine arterial injury
odel and the ultrasound microbubble method. We chose 1
f 7 ICAM-1 siRNAs after MLR evaluation for in vivo
ransfection. Immediately after arterial injury, 90 l ICAM-1
iRNA (20 g) plus microbubble (10 l) mixture was incu-
ated within the arterial lumen. The ultrasound was irradiated
or 20 s (1 MHz, 0.5 W/cm2, duty 50%) to the artery. For
ontrol studies, 1) no siRNA without microbubble and ultra-
ound; 2) ICAM-1 siRNA without microbubble and ultra-
ound; and 3) ICAM-1 siRNA with microbubble but no
ltrasound irradiation were performed. To compare the
n vivo effects between ICAM-1 and VCAM-1 for neo-
ntimal formation, we performed VCAM-1 siRNA
SiRNA ID: s67996, Ambion, Foster City, California)
ransfection using the same animal models and methodolo-
ies. In regard to recent concerns that gene specific therapeutic
enefits with siRNA may be the result of nonspecific off-target
ffects, scrambled siRNA (SiRNA ID: AM4611, Ambion)
Figure 2 Representative Findings of Injured Femoral Arteries in
(A, B) Arteries transfected with green fluorescent protein (GFP) small interfering rib
copy. (A) Expression of GFP is enhanced in the target arteries because there was
is a significant decrease of GFP expression in the artery with GFP siRNA and micro
remained because the bottom of the arteries could not receive enough ultrasound
artery is shown. The transfection efficiency of the GFP siRNA using the ultrasound
limited transfection of siRNA did not alter GFP expression in the remote arteries oas also transfected using the same animal models and
ethodologies. The arteries were harvested on day 28.
uantitative assessment of arterial neointima. Tissue
ections were stained with hematoxylin and eosin and
lastica van Gieson. Light microscopic morphometric com-
uter analysis was carried out. The severity of neointimal
ormation was quantitatively assessed in each artery, as
escribed earlier (4). The areas encompassed by the outer
edial layer (OML), the inner elastic lamina (IEL), and the
umen were measured, and the length of intimal thickening
IT) in relation to the length of medial wall was calculated
y the formula: IT (IEL lumen area) / (OML IEL).
mmunohistochemistry. Complete transverse sections of
he arteries approximately 3 mm in length were obtained
nd stored in an optimum cutting temperature compound
Ted Pella, Inc., Redding, California). Serial sections (6
m) were cut and dipped in cold acetone for 10 min. The
ections were rehydrated in phosphate buffered saline (PBS)
Overexpressing Mice
eic acid (siRNA) harvested 7 days after transfection using fluorescent micros-
rasound irradiation for GFP siRNA without microbubble administration. (B) There
administration and ultrasound irradiation. The partial expression of GFP
tion using this perivascular approach. (C) The number of GFP-positive cells per
ubble method was significantly increased compared with the control groups. The
ice. *p  0.05. Scale bars  0.5 mm.GFP
onucl
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ICAM-1 siRNA Attenuates Neointimal Formation March 2, 2010:904–13nd incubated with 5% normal goat serum to avoid non-
pecific reaction. The samples were incubated with primary
ntibodies against ICAM-1 (YN1/1.7), VCAM-1 (MK/2),
D4 (GK1.5), CD8 (53-6.7), and CD11b (M1/70
Pharmingen, San Diego, California]), CD31 (H-300
Santa Cruz, San Diego, California]), and proliferating cell
uclear antigen (PC10 [Sigma Aldrich, Tokyo, Japan]) for
2 h at 4°C. Biotin-conjugated antibodies were detected
ith an avidin-biotin-horseradish peroxidase complex
Nichirei, Tokyo, Japan) according to the manufacturer’s
nstructions. Enzyme activity was detected with diamino-
enzidine (0.5 mg/ml) with 0.05% NiCl in 50 mM Tris
uffer, pH 7.5 (4,12). We counted positive cell numbers per
rtery for CD4, CD8, CD11b, and proliferating cell nuclear
ntigen. Immunohistochemical analyses for ICAM-1,
CAM-1, and CD31 were performed by independent
bservers using qualitative scoring as previously reported (0,
bsent; 1, weak, focal; 2, weak, diffuse; 3, strong, focal; 4,
trong, diffuse; and 5, very strong and diffuse). Scores
niformly fell within 1 grade of each other and were
veraged (9).
eal-time polymerase chain reaction (RT-PCR). RT-PCR
as used to determine the messenger ribonucleic acid
mRNA) expression of ICAM-1 (assay ID: 00516023_m1,
pplied Biosystems). To account for differences in cDNA
reparation and cDNA amplification efficiency, the mRNA
xpression of the target gene was normalized by 18s ribosomal
NA (assay ID: 4308329). Quantitative data were calculated
sing the comparative CT (CT) method (17).
tatistical analysis. All data are expressed as mean  SD.
cores were compared among the groups using a Scheffe
nalysis of variance with Scheffe tests for post-hoc compar-
sons. Differences with values of p  0.05 were considered
ignificant.
esults
ltrasound-microbubble method enhanced FITC-labeled
iRNA transfection into target arteries. At 8 h after trans-
ection, enhanced expression of fluorescence in cell nuclei of
he endothelial cells, medial vascular smooth muscle cells,
nd perivascular cells was observed in the ultrasound micro-
ubble group. However, only faint fluorescence was observed
n the target arteries of the control groups. The transfection
fficiency of the FITC-labeled siRNA using the ultrasound-
icrobubble method was significantly increased compared to
he control groups. To compare the transfection efficiency
etween de-endothelialized and non–de-endothelialized ves-
els, we used the same FITC siRNA and the ultrasound-
icrobubble method. We revealed that there was no statistical
ifference in the efficiency between the 2 groups (Fig. 1,
upplemental Figure 1). No dissemination of FITC-labeled
iRNA in the nonirradiated organs was observed. No systemic
dverse effect was observed in the mice during the observation
eriod.ltrasound-microbubble–mediated GFP siRNA trans-
ection suppressed GFP expression in target arteries. At
days after transfection, suppressed expression of GFP in
ell nuclei of the endothelial cells, medial vascular smooth
uscle cells, and perivascular cells was observed in the
ltrasound-microbubble–mediated GFP siRNA transfec-
ion group. The partial expression of GFP was remaining
ecause the bottom of the arteries could not receive enough
ltrasound irradiation using this perivascular approach. In
ontrast, overexpressed GFP was observed in the target
rteries of the control groups. The transfection efficiency of
he GFP siRNA using the ultrasound-microbubble method
as significantly increased compared with that of the
ontrol groups. We also observed GFP expression in the
emote arteries of GFP transgenic mice. We revealed that
imited transfection of siRNA did not alter expression in the
emote arteries of the mice (Fig. 2).
CAM-1 siRNA transfection with ultrasound-microbubble
ethod could suppress neointimal formation. Before the
n vivo study of ICAM-1 siRNA, we examined in vitro
LR to evaluate the silencing effect of several murine
CAM-1 siRNAs in the suppression of the immune reac-
ion. All sequences had suppressive effects compared to the
roliferation without siRNA administration in the assay
Fig. 3). Thus, we selected the most effective sequence (S1)
mong the 7 sequences for in vivo analysis.
On the basis of these results, we made murine arterial
njury models. The ICAM-1 siRNA plus microbubble
ixture was incubated within the arterial lumen and then
ltrasound irradiated. In the 3 groups of controls, injured
rteries on day 28 showed significantly thickened intima,
hereas the ICAM-1 siRNA with microbubble and ultra-
ound group showed suppressed neointimal formation.
here was significant difference between the treated group
ICAM-1 siRNA, microbubble and ultrasound) and the 3
ontrol groups. The VCAM-1 siRNA had a statistically
omparable effect to that of ICAM-1 siRNA in the pre-
ention of neointimal formation. The scrambled siRNA did
Figure 3 Results of MLR to Assess Which
ICAM-1 siRNA Sequence Is Most Effective
C  mixed lymphocyte reaction (MLR) without intercellular adhesion molecule
(ICAM)-1 small interfering ribonucleic acid (siRNA); N  no stimulator cells; S1
to S7  MLR with each ICAM-1 siRNA. *p  0.05 versus C.
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March 2, 2010:904–13 ICAM-1 siRNA Attenuates Neointimal Formationot suppress neointimal formation (Fig. 4). No neointimal
ormation was detected in native arteries and arteries from
ham-operated mice.
To clarify the mechanism, we performed immunohisto-
hemistry. ICAM-1 was much more intensely expressed in the
hickened intima of the injured arteries in the control groups,
hereas the expression was reduced in the arteries from mice
hat received the ICAM-1 siRNA with microbubble and
ltrasound. VCAM-1 was also enhanced in the thickened
ntima of the injured arteries from the control groups, whereas
Figure 4 Arteries Harvested, Stained With EvG, and Quantitativ
(A to D) Arteries harvested on day 28 stained with Elastica van Gieson (EvG). (A)
acid (siRNA) intercellular adhesion molecule (ICAM)-1 without ultrasound irradiation
ICAM-1 siRNA with microbubble administration and ultrasound irradiation. (C) Vasc
ICAM-1 siRNA in the prevention of neointimal formation. (D) The scrambled siRNA
ing. The siRNA using the ultrasound-microbubble method significantly suppressed
elastic lamina, and arrowheads indicate endothelium. *p  0.05 versus no siRNAhe expression was reduced in the arteries from mice that weceived the treatment. The scores of ICAM-1 and VCAM-1
ere significantly reduced after ICAM-1 siRNA with ultra-
ound treatment. The CD4, CD8, and CD11b positive cells
ere severely infiltrated into the thickened intima of the
ontrol arteries, while these positive cells were suppressed in
he ICAM-1 siRNA in the microbubble-ultrasound–treated
roup. We compared re-endothelialization and cell prolifera-
ion between the ICAM-1 siRNA group and the non-
reated group. Although cell proliferation was suppressed
n the siRNA ICAM-1 transfected arteries compared
sults of Intimal Thickening
cantly thickened intima in the arteries is seen with small interfering ribonucleic
ever, B shows significant suppression of neointimal formation in the artery with
ell adhesion molecule-1 siRNA had an effect statistically comparable to that of
t suppress neointimal formation. (E) The quantitative results of intimal thicken-
ointimal formation compared with the other groups. Arrows indicate internal
. Scale bars  0.5 mm.e Re
Signifi
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did no
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groupith the vehicle-treated arteries, there was no difference
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ICAM-1 siRNA Attenuates Neointimal Formation March 2, 2010:904–13n re-endothelialization between the 2 groups. No CD4,
D8, CD11b, ICAM-1, and VCAM-1 expression was en-
anced in native arteries and arteries from sham-operated mice
Figs. 5 and 6).
The RT-PCR revealed that the mRNA levels of
CAM-1 were elevated in vehicle-treated arteries after the
ire injury, whereas siRNA ICAM-1 treatment signifi-
antly suppressed the levels (Fig. 7).
iscussion
n this study, we demonstrated that the ultrasound-
icrobubble method enhanced the selective transfection
fficiency of siRNA. Previous studies have indicated that the
herapeutic application of siRNAs is largely dependent upon
he development of a delivery vehicle that can efficiently
eliver the siRNAs to target cells. Sioud et al. (18) indicated
hat they could deliver a fluorescein-labeled siRNA using
Figure 5 Representative Results of Immunohistochemistry Det
Representative results of immunohistochemistry detecting (A, B) intercellular adhe
F) CD31 are shown. The artery without small interfering ribonucleic acid (siRNA) tr
thickened intima. However, the artery with ICAM-1 siRNA with microbubble plus ult
brown-colored cells) were suppressed in the siRNA ICAM-1 transfected arteries co
sion (E and F, brown-colored cells) between the 2 groups. Arrows indicate positivationic liposome-mediated intravenous and intraperitoneal
dministration in adult mice. Although they showed that
he cationic liposome-mediated transfection could deliver
iRNAs into various cell types, this method could not limit the
ransfection into targeted tissues; that may disseminate the
iRNA in whole bodies for systemic adverse effects. However,
s we have shown in this study, the ultrasound-microbubble
ethod can deliver siRNA into target tissues and prevent
ystemic adverse effects because siRNA was not transfected
nto nonultrasound areas. The use of ultrasound-mediated
icrobubble destruction for gene therapy was pioneered by
hohet et al. (19). They revealed that ultrasound-mediated
estruction of albumin-coated microbubbles is a promising
ethod for the delivery of bioactive agents to the heart.
indner et al. (20) also pioneered the use of microbubbles
argeted to ICAM-1 and other markers of vascular endo-
helium. They formulated novel microbubbles that were
g ICAM-1, PCNA, and CD31
olecule (ICAM)-1, (C, D) proliferating cell nuclear antigen (PCNA), and (E,
tion (A) shows enhancement of ICAM-1 (A and B, brown-colored cells) in the
d shows suppression of ICAM-1 expression. The PCNA-positive cells (C and D,
d with the vehicle treatment. However, there was no difference in CD31 expres-
. Scale bars  0.5 mm.ectin
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March 2, 2010:904–13 ICAM-1 siRNA Attenuates Neointimal Formationargeted to endothelial cell adhesion molecules, including
-selectin and ICAM-1, for imaging inflamed tissues (20).
ecause these 2 laboratories pioneered the whole field of
ltrasound-targeted microbubble destruction, both for gene
elivery/therapy and diagnostic imaging, we could develop
ew techniques using siRNA to ICAM-1. Thus, the
ltrasound-microbubble method is a novel, nonviral, effec-
ive, and safe method of in vivo gene transfer.
Using this methodology, we have revealed that in vivo
ransfection of siRNA against ICAM-1 significantly sup-
ressed neointimal formation and inflammation without
ystemic adverse effects. As previously reported, activated
eukocytes, neutrophils, monocytes, and platelets play a
ritical role in the initial stage of the inflammatory process
fter vascular injury. Firstly, platelets and fibrin are depos-
ted on the injured arterial surface and activated platelets
xpress adhesion molecules. Adhesion molecules mediate
he initial tethering and rolling of leukocytes on platelets.
eukocytes then adhere firmly to the vessel surface through
ac-1 (CD11b/CD18) by a ligand-receptor interaction with
brinogen to the glycoprotein IIb/IIIa receptor (21). Worthy
f note, platelets will adhere to the de-endothelialized artery,
nd could also use ICAM-1 as a receptor for glycoprotein
Figure 6 Quantitative Results of Immunohistochemistry Evalua
Quantitative results of immunohistochemistry evaluating (A) CD8, (B) CD11b, (C)
sus no siRNA group. Abbreviations as in Figure 5.Ib/IIIa–bound fibrinogen (22). These inflammatory processes rre followed by proliferation of vascular components, such as
mooth muscle cells and extracellular matrix, leading to neo-
ntimal thickening.
Hill et al. (23) reported that silencing interleukin-12
roduction in dendritic cells using siRNA was effective in
ecreasing allostimulation in vitro and modulated the Th1
ersus Th2 balance in vivo during a primary immune
esponse. Although this approach is useful for systemic
reatment, this cytokine treatment may not be beneficial for
any cardiovascular diseases that need specific and limited
reatments. Cell adhesion molecules are good therapeutic
argets for suppression of various inflammatory and cardio-
ascular diseases.
We have revealed that E-selectin siRNA in vascular endo-
helium leads to inhibition of leukocyte adhesion in vitro (24).
ecause ICAM-1 plays a central role in the progression of
ardiovascular diseases (25), immunomodulation of ICAM-1
sing siRNA could be clinically useful without systemic im-
une modulation and adverse effects. However, the multiple
oles of ICAM-1 suppressing injury-induced neointimal for-
ation are still controversial. Yasukawa et al. (10) reported that
ntravenous administration of ICAM-1 monoclonal antibody
ignificantly attenuated carotid artery neointimal formation in
D8, CD11b, ICAM-1, and VCAM-1
1, and (D) vascular cell adhesion molecule (VCAM)-1 are shown. *p  0.05 ver-ting C
ICAM-esponse to injury compared with that of control animals.
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ation of monocytes/macrophages within the injured vessels,
ndicating the role of other ICAM-1–dependent events in
estenosis (10). Manka et al. (26) reported no effect of
CAM-1 deficiency on macrophage accumulation in
polipoprotein-E knockout mice. We speculate that siRNA
CAM-1 reduced neointimal formation through suppression
f T-cell accumulation and expression of other adhesion
olecules, although macrophage accumulation plays an impor-
ant role in the development of neointimal formation after
rterial injury. Of note, siRNA against ICAM-1 inhibited
CAM-1 expression after injury. This finding may imply an
ndirect mechanism by which inflammatory cells adhering to
CAM-1 induce VCAM-1. Although the event was sup-
orted by previous investigations (27), the detailed in vivo
echanism of siRNA against ICAM-1 remains unclear. Thus,
urther investigation is needed to elucidate the mechanisms of
iRNA ICAM-1 in cardiovascular diseases.
onclusions
he ultrasound-microbubble delivery of siRNAs is effective
or transfection into target arteries in vivo. Using this
ethod, ICAM-1 siRNA is potent for the suppression of
eointimal formation after coronary angioplasty. Thus, this
onviral transfection of siRNA may be beneficial for the
linical treatment of cardiovascular diseases and other in-
ammatory diseases.
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APPENDIX
or a supplemental figure showing the representative finding of untreated
njured femoral artery in wild-type mice on day 28 after injury, please see
he online version of this article
